Immunocore Property Plant Equipment vs Total Current Assets Analysis

IMCR Stock

USD 58.46 0.46 0.79%

Immunocore Holdings financial indicator trend analysis is infinitely more than just investigating Immunocore Holdings recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunocore Holdings is a good investment. Please check the relationship between Immunocore Holdings Property Plant Equipment and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.

Property Plant Equipment vs Total Current Assets

Property Plant Equipment vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immunocore Holdings Property Plant Equipment account and Total Current Assets. At this time, the significance of the direction appears to have very week relationship.

The correlation between Immunocore Holdings' Property Plant Equipment and Total Current Assets is 0.24. Overlapping area represents the amount of variation of Property Plant Equipment that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Immunocore Holdings, assuming nothing else is changed. The correlation between historical values of Immunocore Holdings' Property Plant Equipment and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant Equipment of Immunocore Holdings are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Property Plant Equipment i.e., Immunocore Holdings' Property Plant Equipment and Total Current Assets go up and down completely randomly.

Correlation Coefficient

0.24

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Property Plant Equipment

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most indicators from Immunocore Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunocore Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.At this time, Immunocore Holdings' Tax Provision is relatively stable compared to the past year. As of 04/28/2024, Enterprise Value is likely to grow to about 3.5 T, while Selling General Administrative is likely to drop slightly above 84.5 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	47K	3.2M	4.1M	4.7M
Interest Income	47K	3.2M	12.5M	13.1M

Depreciation And Amortization Interest Income

Immunocore Holdings fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Assets	Net Receivables	Other Stockholder Equity	Total Current Assets	Property Plant Equipment	Other Current Assets	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Total Liab
Other Current Liab		0.59	-0.21	0.59	-0.77	-0.01	0.12	0.48	0.91	0.56	0.27	0.04	0.63	0.46	0.76	0.39	-0.77	0.59	0.55	0.54	0.5	0.59	-0.45	-0.26	0.49	0.77
Total Current Liabilities	0.59		-0.18	0.33	-0.85	0.54	0.32	0.91	0.8	0.75	0.8	0.5	0.85	0.9	0.73	0.81	-0.65	0.79	0.94	0.24	0.92	0.79	-0.71	-0.39	-0.01	0.87
Other Liab	-0.21	-0.18		-0.77	0.37	-0.39	-0.32	0.07	-0.3	-0.54	0.02	0.32	-0.53	-0.38	-0.59	-0.05	0.61	-0.58	-0.21	0.04	-0.37	-0.58	0.54	0.46	-0.47	-0.25
Net Tangible Assets	0.59	0.33	-0.77		-0.48	0.41	0.08	0.22	0.53	0.77	-0.12	-0.46	0.74	0.34	0.84	0.02	-0.9	0.76	0.25	0.3	0.36	0.76	-0.48	-0.46	0.79	0.5
Retained Earnings	-0.77	-0.85	0.37	-0.48		-0.41	-0.28	-0.69	-0.95	-0.66	-0.69	-0.42	-0.78	-0.89	-0.85	-0.73	0.77	-0.75	-0.85	-0.12	-0.9	-0.75	0.84	0.63	-0.14	-0.76
Accounts Payable	-0.01	0.54	-0.39	0.41	-0.41		0.33	0.64	0.26	0.57	0.46	0.1	0.61	0.64	0.6	0.37	-0.54	0.64	0.43	-0.11	0.63	0.64	-0.66	-0.72	0.14	0.24
Other Assets	0.12	0.32	-0.32	0.08	-0.28	0.33		0.31	0.2	0.17	0.42	0.06	0.29	0.29	0.26	0.2	-0.24	0.29	0.25	0.05	0.29	0.29	-0.28	-0.18	0.06	0.21
Net Receivables	0.48	0.91	0.07	0.22	-0.69	0.64	0.31		0.67	0.62	0.76	0.46	0.73	0.77	0.64	0.72	-0.56	0.67	0.8	0.3	0.78	0.67	-0.57	-0.39	-0.01	0.73
Other Stockholder Equity	0.91	0.8	-0.3	0.53	-0.95	0.26	0.2	0.67		0.63	0.59	0.33	0.74	0.77	0.85	0.68	-0.79	0.7	0.81	0.39	0.8	0.7	-0.72	-0.49	0.26	0.83
Total Current Assets	0.56	0.75	-0.54	0.77	-0.66	0.57	0.17	0.62	0.63		0.24	-0.14	0.98	0.66	0.85	0.32	-0.88	0.98	0.58	0.22	0.67	0.98	-0.66	-0.33	0.55	0.75
Property Plant Equipment	0.27	0.8	0.02	-0.12	-0.69	0.46	0.42	0.76	0.59	0.24		0.86	0.41	0.83	0.38	0.94	-0.22	0.34	0.88	0.06	0.83	0.34	-0.58	-0.44	-0.5	0.55
Other Current Assets	0.04	0.5	0.32	-0.46	-0.42	0.1	0.06	0.46	0.33	-0.14	0.86		0.0	0.55	-0.02	0.85	0.18	-0.08	0.68	-0.12	0.55	-0.08	-0.23	-0.23	-0.82	0.29
Total Assets	0.63	0.85	-0.53	0.74	-0.78	0.61	0.29	0.73	0.74	0.98	0.41	0.0		0.77	0.9	0.46	-0.9	0.99	0.7	0.25	0.78	0.99	-0.74	-0.42	0.46	0.82
Short Long Term Debt Total	0.46	0.9	-0.38	0.34	-0.89	0.64	0.29	0.77	0.77	0.66	0.83	0.55	0.77		0.74	0.85	-0.62	0.74	0.92	0.07	1.0	0.74	-0.9	-0.62	-0.08	0.69
Total Stockholder Equity	0.76	0.73	-0.59	0.84	-0.85	0.6	0.26	0.64	0.85	0.85	0.38	-0.02	0.9	0.74		0.45	-0.98	0.9	0.64	0.28	0.76	0.9	-0.79	-0.67	0.55	0.72
Property Plant And Equipment Net	0.39	0.81	-0.05	0.02	-0.73	0.37	0.2	0.72	0.68	0.32	0.94	0.85	0.46	0.85	0.45		-0.29	0.38	0.95	0.19	0.86	0.38	-0.55	-0.41	-0.46	0.69
Net Debt	-0.77	-0.65	0.61	-0.9	0.77	-0.54	-0.24	-0.56	-0.79	-0.88	-0.22	0.18	-0.9	-0.62	-0.98	-0.29		-0.91	-0.53	-0.3	-0.64	-0.91	0.71	0.58	-0.68	-0.69
Cash	0.59	0.79	-0.58	0.76	-0.75	0.64	0.29	0.67	0.7	0.98	0.34	-0.08	0.99	0.74	0.9	0.38	-0.91		0.63	0.17	0.75	1.0	-0.77	-0.46	0.52	0.73
Non Current Assets Total	0.55	0.94	-0.21	0.25	-0.85	0.43	0.25	0.8	0.81	0.58	0.88	0.68	0.7	0.92	0.64	0.95	-0.53	0.63		0.26	0.94	0.63	-0.68	-0.41	-0.21	0.84
Non Currrent Assets Other	0.54	0.24	0.04	0.3	-0.12	-0.11	0.05	0.3	0.39	0.22	0.06	-0.12	0.25	0.07	0.28	0.19	-0.3	0.17	0.26		0.1	0.17	0.04	0.25	0.34	0.55
Long Term Debt	0.5	0.92	-0.37	0.36	-0.9	0.63	0.29	0.78	0.8	0.67	0.83	0.55	0.78	1.0	0.76	0.86	-0.64	0.75	0.94	0.1		0.75	-0.88	-0.61	-0.06	0.73
Cash And Short Term Investments	0.59	0.79	-0.58	0.76	-0.75	0.64	0.29	0.67	0.7	0.98	0.34	-0.08	0.99	0.74	0.9	0.38	-0.91	1.0	0.63	0.17	0.75		-0.77	-0.46	0.52	0.73
Common Stock Shares Outstanding	-0.45	-0.71	0.54	-0.48	0.84	-0.66	-0.28	-0.57	-0.72	-0.66	-0.58	-0.23	-0.74	-0.9	-0.79	-0.55	0.71	-0.77	-0.68	0.04	-0.88	-0.77		0.73	-0.22	-0.48
Non Current Liabilities Total	-0.26	-0.39	0.46	-0.46	0.63	-0.72	-0.18	-0.39	-0.49	-0.33	-0.44	-0.23	-0.42	-0.62	-0.67	-0.41	0.58	-0.46	-0.41	0.25	-0.61	-0.46	0.73		-0.12	-0.13
Inventory	0.49	-0.01	-0.47	0.79	-0.14	0.14	0.06	-0.01	0.26	0.55	-0.5	-0.82	0.46	-0.08	0.55	-0.46	-0.68	0.52	-0.21	0.34	-0.06	0.52	-0.22	-0.12		0.18
Total Liab	0.77	0.87	-0.25	0.5	-0.76	0.24	0.21	0.73	0.83	0.75	0.55	0.29	0.82	0.69	0.72	0.69	-0.69	0.73	0.84	0.55	0.73	0.73	-0.48	-0.13	0.18

Click cells to compare fundamentals

Immunocore Holdings Account Relationship Matchups

Immunocore Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Other Current Liab	5.1M	20.1M	39K	51K	114.3M	120.0M
Total Current Liabilities	84.5M	55.0M	61.2M	83.1M	139.0M	72.0M
Other Liab	48.1M	25.0M	6.5M	5.9M	5.3M	5.1M
Net Tangible Assets	14.8M	55.3M	171.5M	278.3M	320.1M	336.1M
Retained Earnings	(279.1M)	(349.9M)	(481.4M)	(261.3M)	(744.7M)	(707.4M)
Accounts Payable	15.7M	5.8M	35.4M	75.1M	17.8M	23.0M
Other Assets	6.5M	7.2M	7.5M	11.6M	10.4M	7.5M
Net Receivables	50.0M	23.2M	24.8M	58.4M	61.4M	40.2M
Other Stockholder Equity	293.9M	405.1M	266.6M	205.2M	1.1B	1.2B
Total Current Assets	124.3M	152.9M	262.7M	391.9M	528.8M	270.4M
Property Plant Equipment	54.9M	36.8M	31.5M	31.6M	36.4M	33.1M
Other Current Assets	48.8M	21.2M	18.8M	58.4K	9.7M	12.3M
Total Assets	185.6M	197.2M	301.8M	435.5M	597.0M	350.7M
Short Long Term Debt Total	59.4M	63.9M	63.8M	69.3M	84.0M	65.9M
Total Stockholder Equity	14.8M	55.3M	171.5M	278.8M	368.8M	387.3M
Property Plant And Equipment Net	54.9M	36.8M	31.5M	31.6M	42.7M	40.1M
Net Debt	(14.6M)	(65.8M)	(174.1M)	(263.2M)	(358.6M)	(340.7M)
Cash	74.0M	129.7M	237.9M	332.5M	442.6M	245.9M
Non Current Assets Total	61.4M	44.3M	39.0M	43.6M	68.2M	51.5M
Non Currrent Assets Other	4.4M	4.2M	(31.5M)	7.2M	14.5M	15.2M
Cash And Short Term Investments	74.0M	129.7M	237.9M	332.5M	442.6M	245.9M
Liabilities And Stockholders Equity	185.6M	197.2M	301.8M	435.5M	597.0M	350.7M
Non Current Liabilities Total	86.4M	86.9M	69.0M	73.7M	89.1M	66.0M
Capital Lease Obligations	40.3M	27.2M	26.6M	29.8M	36.0M	29.3M
Inventory	(48.6M)	(21.2M)	(18.8M)	943K	4.5M	4.7M
Total Liab	170.9M	141.8M	130.2M	156.8M	228.2M	177.3M
Net Invested Capital	33.9M	92M	208.8M	318.3M	416.9M	210.0M
Long Term Investments	591K	973K	165K	137K	123.3K	117.1K
Property Plant And Equipment Gross	54.9M	36.8M	31.5M	31.6M	95.0M	49.7M
Accumulated Other Comprehensive Income	(32K)	163K	386.3M	334.8M	(36.3M)	(34.4M)
Net Working Capital	39.8M	97.9M	201.5M	308.8M	389.8M	212.6M

Immunocore Holdings Investors Sentiment

The influence of Immunocore Holdings' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Immunocore. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Immunocore Holdings' public news can be used to forecast risks associated with an investment in Immunocore. The trend in average sentiment can be used to explain how an investor holding Immunocore can time the market purely based on public headlines and social activities around Immunocore Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Immunocore Holdings' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Immunocore Holdings' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Immunocore Holdings' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Immunocore Holdings.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immunocore Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immunocore Holdings' short interest history, or implied volatility extrapolated from Immunocore Holdings options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Immunocore Holdings is a strong investment it is important to analyze Immunocore Holdings' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunocore Holdings' future performance. For an informed investment choice regarding Immunocore Stock, refer to the following important reports:

How To Invest In Immunocore

Details

Is Immunocore Stock a good investment?

Details

What is Immunocore Holdings' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunocore Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

To learn how to invest in Immunocore Stock, please use our How to Invest in Immunocore Holdings guide.

Note that the Immunocore Holdings information on this page should be used as a complementary analysis to other Immunocore Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Immunocore Stock analysis

When running Immunocore Holdings' price analysis, check to measure Immunocore Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunocore Holdings is operating at the current time. Most of Immunocore Holdings' value examination focuses on studying past and present price action to predict the probability of Immunocore Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunocore Holdings' price. Additionally, you may evaluate how the addition of Immunocore Holdings to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios

Is Immunocore Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunocore Holdings. If investors know Immunocore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunocore Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.68)

Earnings Share

(1.41)

Revenue Per Share

5.102

Quarterly Revenue Growth

0.122

Return On Assets

(0.07)

The market value of Immunocore Holdings is measured differently than its book value, which is the value of Immunocore that is recorded on the company's balance sheet. Investors also form their own opinion of Immunocore Holdings' value that differs from its market value or its book value, called intrinsic value, which is Immunocore Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunocore Holdings' market value can be influenced by many factors that don't directly affect Immunocore Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immunocore Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunocore Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunocore Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Immunocore Property Plant Equipment vs Total Current Assets Analysis

Property Plant Equipment vs Total Current Assets

Property Plant Equipment vs Total Current Assets Correlation Analysis

Correlation Coefficient

Property Plant Equipment

Total Current Assets

Immunocore Holdings fundamental ratios Correlations

Immunocore Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Immunocore Holdings fundamental ratios Accounts

Immunocore Holdings Investors Sentiment

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Immunocore Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Debt	+ 1.0	Short Long Term Debt Total
Cash And Short Term Investments	+ 1.0	Cash
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Assets	+ 0.98	Total Current Assets
Cash	+ 0.98	Total Current Assets

Net Debt	- 0.98	Total Stockholder Equity
Other Stockholder Equity	- 0.95	Retained Earnings
Cash And Short Term Investments	- 0.91	Net Debt
Cash	- 0.91	Net Debt
Common Stock Shares Outstanding	- 0.9	Short Long Term Debt Total
Net Debt	- 0.9	Total Assets